Lv1
10 积分 2025-05-28 加入
Impact of HER2-low status for patients with early-stage breast cancer and non-pCR after neoadjuvant chemotherapy: a National Cancer Database Analysis
7小时前
待确认
Neoadjuvant chemotherapy efficacy and prognosis in HER2-low and HER2-zero breast cancer patients by HR status: a retrospective study in China
7小时前
求助中
Comparison of the Pathological Complete Response Rate and Survival Between HER2-Low and HER2-Zero Breast Cancer in Neoadjuvant Chemotherapy Setting: A Systematic Review and Meta-Analysis
7小时前
已完结
Real-World Outcomes of Pyrotinib-Based Therapy for HER2-Positive Breast Cancer With Brain Metastases: A Multicentre, Retrospective Analysis
19天前
已完结
Homologous recombination deficiency and hemizygosity drive resistance in breast cancer
1个月前
已完结
FANCI Inhibition Induces PARP1 Redistribution to Enhance the Efficacy of PARP Inhibitors in Breast Cancer
1个月前
已完结
Axillary Surgery in Breast Cancer — Primary Results of the INSEMA Trial
3个月前
已完结
Palbociclib for Hormone-Receptor–Positive, HER2-Positive Advanced Breast Cancer
3个月前
已完结
Whole-Brain Radiotherapy Alone vs Preceded by Bevacizumab, Etoposide, and Cisplatin for Untreated Brain Metastases From Breast Cancer
4个月前
已完结
Efficacy and safety of a “sandwich therapy” based on staged stereotactic radiosurgery and bevacizumab for large brainstem metastases
4个月前
已完结
皖公网安备34019202002308
